🇺🇸 FDA
Patent

US 7101863

Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative

granted A61KA61K31/721A61P

Quick answer

US patent 7101863 (Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative) held by BIODEX expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIODEX
Grant date
Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/721, A61P, A61P1/04, A61P17/00